Skip to content

The correlation between the fraction of flow reserve (FFR) and the effect of coronary artery bypass grafting (CABG)

The correlation between the fraction of flow reserve (FFR) and the effect of coronary artery bypass grafting (CABG)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082128
Enrollment
Unknown
Registered
2024-03-21
Start date
2024-03-22
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease

Interventions

Complete vascularization group (Any target coronary artery was measured FFR=0.8, and CABG surgery was performed):None
Incomplete vascularization group (FFR=0.8 was measured in any target coronary artery, but CABG was not performed):None
Non-hypervascularization group (All target coronary arteries were measured with FFR > 0.8, and CABG surgery was not performed):None
Hypervascularization group (FFR > 0.8 was measured in all target coronary arteries and CABG was performed):None

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age>18 years old 2.All cardiac surgical patients with a single diagnosis of coronary heart disease or a combined diagnosis of coronary heart disease (Including individuals with simple coronary heart disease, valvular heart disease combined with coronary heart disease, and congenital heart disease combined with coronary heart disease); 3.Preoperative coronary angiography showed 30-80% stenosis of at least one coronary artery

Exclusion criteria

Exclusion criteria: 1.Acute myocardial infarction, emergency surgery, previous cardiac surgery history 2.Patients who are difficult to perform coronary angiography for various reasons (such as aortic dissection, contrast agent allergy, etc.) 3.Target coronary artery can not determine FFR 4.Preoperative LVEF 150µmol/L

Design outcomes

Primary

MeasureTime frame
Graft vascular occlusion rate;

Secondary

MeasureTime frame
Major adverse cardiac events (MACE);All-cause mortality;

Countries

China

Contacts

Public ContactMai Chen

The First Affiliated Hospital of Guangxi Medical University

921126@sr.gxmu.edu.cn+86 187 7674 3915

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026